| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $236K | — | +29.9% |
| SG&A Expense | $288K | — | -14.9% |
| Pre-tax Income | -$387K | — | -45.7% |
| Net Income | -$387K | — | -45.7% |
| EPS (Basic) | -$0.02 | — | -100.0% |
| EPS (Diluted) | -$0.02 | — | -100.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $5.8M | -3.1% | — |
| Total Assets | $6.2M | -4.1% | — |
| Current Liabilities | $3.0M | +5.4% | — |
| Total Liabilities | $3.2M | +6.7% | — |
| Stockholders' Equity | $3.0M | -13.6% | +174.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$610K | — | -1956.4% |
| Capital Expenditures | $2K | — | -91.1% |
| Investing Cash Flow | -$2K | — | +91.1% |
| Financing Cash Flow | $447K | — | +14.0% |
| Free Cash Flow | -$612K | — | -1132.7% |